Opendata, web and dolomites

ASSYSt SIGNED

A reliable CXCL4 biomarker assay to improve diagnosis and treatment of Systemic Sclerosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ASSYSt project word cloud

Explore the words cloud of the ASSYSt project. It provides you a very rough idea of what is the project "ASSYSt" about.

therapeutic    patients    excessive    heart    cohorts    lack    aetiology    decision    prognosis    joints    complicates    central    vitro    assyst    organ    prevention    demonstrated    accessible    adequately    kidneys    strategies    protocols    half    erc    exacerbated    treatment    guide    complications    accelerate    disease    complement    assist    course    tissue    disorder    biomarker    die    validate    treatments    matrix    sensitive    cxcl4    diagnostic    irrespective    scleroderma    labs    route    ultimately    predict    medical    argue    fibrosis    cheap    experiments    molecular    sclerosis    measuring    clinical    strategy    pathogenesis    scarring    replication    lacking    lung    suggest    circulating    autoimmune    curative    assay    extracellular    player    prohibits    team    chemokine    outcome    markers    diagnosis    of    organs    listed    levels    tool    ssc    unclear    storage    circumvent    deposition    fast    assessing    grant    systemic    business    multiple    starting    culminating    skin    gastrointestinal    collection    tract    internal    market   

Project "ASSYSt" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAIR MEDISCH CENTRUM UTRECHT 

Organization address
address: HEIDELBERGLAAN 100
city: UTRECHT
postcode: 3584 CX
website: www.umcutrecht.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-PoC
 Funding Scheme ERC-POC
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAIR MEDISCH CENTRUM UTRECHT NL (UTRECHT) coordinator 150˙000.00

Map

 Project objective

Systemic Sclerosis (SSc, scleroderma) is a complex autoimmune disorder of unclear aetiology, culminating in excessive extracellular matrix deposition (fibrosis/tissue scarring) in skin and internal organs (e.g. joints, heart, lung, gastrointestinal tract and kidneys). More than half of the patients will ultimately die as a result of organ complications. The medical need is exacerbated by the lack of curative treatments and the lack of specific and sensitive molecular markers to facilitate reliable diagnosis and prognosis.

My team has recently demonstrated, through research funded by the ERC Starting Grant CIRCUMVENT, that the chemokine CXCL4 is a central player in the pathogenesis of SSc. Our results suggest that CXCL4 has great potential as 1) a biomarker to assist early diagnosis, 2) a biomarker to predict SSc disease course, and 3) a therapeutic target for the treatment or prevention of fibrosis in patients with SSc. Currently, a robust, accessible, reliable, cheap and fast assay to determine CXCL4 levels for clinical use is lacking. This prohibits the use of CXCL4 to predict clinical and treatment outcome and complicates the large-scale replication experiments across multiple labs and cohorts that are necessary to validate the diagnostic value of CXCL4.

Therefore, we argue that a reliable in vitro assay measuring circulating CXCL4 levels is highly needed and can be deployed as a research support tool to accelerate the implementation of clinical strategies based on CXCL4 and a clinical decision support tool in SSc to complement current diagnostic protocols. ASSYSt will focus on 1) the development of a reliable assay to adequately determine circulating CXCL4 levels irrespective of sample collection and storage conditions, 2) assessing the market potential of each of the applications listed above, and 3) defining a strong business strategy to guide route to market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ASSYST" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ASSYST" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

NanoPD_P (2020)

High throughput multiplexed trace-analyte screening for diagnostics applications

Read More  

InsideChromatin (2019)

Towards Realistic Modelling of Nucleosome Organization Inside Functional Chromatin Domains

Read More  

HOLI (2019)

Deep Learning for Holistic Inference

Read More